Kanayama A - Search Results

1

Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans.

Kim J, Takahashi M, Shimizu T, Shirasawa T, Kajita M, Kanayama A, Miyamoto Y. Kim J, et al. Among authors: kanayama a. Mech Ageing Dev. 2008 Jun;129(6):322-31. doi: 10.1016/j.mad.2008.02.011. Epub 2008 Mar 2. Mech Ageing Dev. 2008. PMID: 18400258

2

Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide.

Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y. Kajita M, et al. Among authors: kanayama a. Free Radic Res. 2007 Jun;41(6):615-26. doi: 10.1080/10715760601169679. Free Radic Res. 2007. PMID: 17516233

3

Apoptosis triggered by phagocytosis-related oxidative stress through FLIPS down-regulation and JNK activation.

Kanayama A, Miyamoto Y. Kanayama A, et al. J Leukoc Biol. 2007 Nov;82(5):1344-52. doi: 10.1189/jlb.0407259. Epub 2007 Aug 20. J Leukoc Biol. 2007. PMID: 17709401

4

Platinum nanoparticles have an activity similar to mitochondrial NADH:ubiquinone oxidoreductase.

Hikosaka K, Kim J, Kajita M, Kanayama A, Miyamoto Y. Hikosaka K, et al. Among authors: kanayama a. Colloids Surf B Biointerfaces. 2008 Oct 15;66(2):195-200. doi: 10.1016/j.colsurfb.2008.06.008. Epub 2008 Jun 24. Colloids Surf B Biointerfaces. 2008. PMID: 18653320

5

In vitro free radical scavenging activity of platinum nanoparticles.

Watanabe A, Kajita M, Kim J, Kanayama A, Takahashi K, Mashino T, Miyamoto Y. Watanabe A, et al. Among authors: kanayama a. Nanotechnology. 2009 Nov 11;20(45):455105. doi: 10.1088/0957-4484/20/45/455105. Epub 2009 Oct 16. Nanotechnology. 2009. PMID: 19834242

6

ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation.

Park J, Kanayama A, Yamamoto K, Miyamoto Y. Park J, et al. Among authors: kanayama a. Biochem Biophys Res Commun. 2012 Jun 1;422(2):291-7. doi: 10.1016/j.bbrc.2012.04.150. Epub 2012 May 3. Biochem Biophys Res Commun. 2012. PMID: 22580278

7

Modification of IkappaBalpha by taurine bromamine inhibits tumor necrosis factor alpha-induced NF-kappaB activation.

Tokunaga S, Kanayama A, Miyamoto Y. Tokunaga S, et al. Among authors: kanayama a. Inflamm Res. 2007 Nov;56(11):479-86. doi: 10.1007/s00011-007-7016-3. Inflamm Res. 2007. PMID: 18224289

8

Taurine is involved in oxidation of IkappaB alpha at Met45: N-halogenated taurine and anti-inflammatory action.

Miyamoto Y, Kanayama A, Inoue J, Konishi YS, Shimizu M. Miyamoto Y, et al. Among authors: kanayama a. Adv Exp Med Biol. 2003;526:373-80. Adv Exp Med Biol. 2003. PMID: 12908622 No abstract available.

9

Suppression of the TNFalpha-induced increase in IL-1alpha expression by hypochlorite in human corneal epithelial cells.

Mohri M, Reinach PS, Kanayama A, Shimizu M, Moskovitz J, Hisatsune T, Miyamoto Y. Mohri M, et al. Among authors: kanayama a. Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3190-5. Invest Ophthalmol Vis Sci. 2002. PMID: 12356823

10

Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation.

Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y. Kanayama A, et al. J Biol Chem. 2002 Jul 5;277(27):24049-56. doi: 10.1074/jbc.M110832200. Epub 2002 Apr 30. J Biol Chem. 2002. PMID: 11983684 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters